Immune Control immunecontrol.com


Public list: Pharma Startups (4732) Portfolio Company Matchmaking M&A (394)

Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists. Merged with Arginetix to form Corridor Pharmaceuticals Inc.

Immune Control is an early-stage drug discovery company that has developed novel approaches to immune modulation using small molecule, serotonin antagonists. Merged with Arginetix to form Corridor Pharmaceuticals Inc.

Company (Merged)

Phone: 610-941-2928

Fax: 610.567.2045

200 Barr Harbor Drive
Suite 400
West Conshohocken, 19428
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Immune Control $17.8M Jun 17, 2010
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Immune Control Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions for treatment of diseases related to activated lymphocytes Aug 31, 2007 Jul 19, 2011 Patent
Methods for treatment of diseases related to activated lymphocytes Aug 31, 2007 Apr 12, 2011 Patent